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Abstract: Harnessing the potential of cells as complex biosensors promises the potential to 
create sensitive and selective detectors for discrimination of biodefense agents. Here we 
present toxin detection and suggest discrimination using cells in a multianalyte 
microphysiometer (MMP) that is capable of simultaneously measuring flux changes in four 
extracellular analytes (acidification rate, glucose uptake, oxygen uptake, and lactate 
production) in real-time. Differential short-term cellular responses were observed between 
botulinum neurotoxin A and ricin toxin with neuroblastoma cells, alamethicin and anthrax 
protective antigen with RAW macrophages, and cholera toxin, muscarine, 2,4-dinitro-
phenol, and NaF with CHO cells. These results and the post exposure dynamics and 
metabolic recovery observed in each case suggest the usefulness of cell-based detectors to 
discriminate between specific analytes and classes of compounds in a complex matrix, and 
furthermore to make metabolic inferences on the cellular effects of the agents. This may be 
particularly valuable for classifying unknown toxins. 
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1. Introduction  
 
Temporal and spatial interactions between physiological pathways in a cell contain high 
information content regarding normal or abnormal function. Unlike biochemical assays that capture a 
fairly static interaction between two molecules, cell-based assays offer the ability to scan for 
cumulative cellular reactions that can span a wide spectrum of different physiological systems. The 
development and validation of cell-based assays have thus become a significant focus for high-
throughput screening of lead drug compounds [1,2] and absorption, distribution, metabolism, 
excretion, and toxicology (ADMET) assays for preclinical drug screening [3,4]. 
One of the earliest efforts to automate a cell-based assay platform was the Cytosensor 
microphysiometer [5-7], which used a light-addressable potentiometric sensor (LAPS) to measure the 
extracellular acidification rate (ECAR) in cultured cells due to the build-up of acidic by-products. The 
Cytosensor has been used extensively to study receptor pharmacology [8,9], enzyme modulators [10], 
cytotoxins [11], immune effectors [12], ionophores [13], and metabolic effectors [14,15]. While often 
assumed to directly reflect changes in cell metabolism, an increase or decrease in ECAR alone is not a 
robust measure of cell metabolism: it fails to differentiate between aerobic versus anaerobic 
respiration, and a decrease in acidification rate does not necessarily indicate a decrease in cell 
metabolism. While Cytosensors are no longer commercially supported, a number of instruments exist 
in metabolic profiling laboratories and on the secondary market, and we are working with potential 
companies to explore a commercial multianalyte microphysiometer. 
Accurate inferences of metabolic processes require measurement of multiple parameters, each 
possessing different analyte specificity. Recently we reported the incorporation of oxygen [16], 
glucose, and lactate [17] electrodes into the Cytosensor platform, making a multianalyte 
microphysiometer (MMP) that permits concurrent measurement of all four extracellular parameters. 
Changes in glucose and lactate concentrations were measured at enzyme coated platinum electrodes by 
the amperometric detection of hydrogen peroxide, which is a by-product of oxidase enzyme catalysis. 
Oxygen was measured directly by reduction at a Nafion coated platinum electrode. The rate of 
consumption or production of each analyte was represented by peaks during the stop-flow pump cycle 
as the current decreased/increased due to consumption/production of analyte. Changes in peak height 
or area under the peak could then be converted to changes in concentration by comparison to in situ 
calibration curves [17]. 
We have employed the MMP to characterize the responses of different cell lines to various toxins 
and metabolic agents [17]. We report here the ability of the metabolic measurements to discriminate in 
real time between acute exposure of a neuroblastoma cell line to ricin toxin (RT) and botulinum 
neurotoxin A (BoNT/A). In addition, we report metabolic discrimination between the two pore-
forming agents: alamethicin (Ala) and anthrax protective antigen (PA) in RAW macrophages, and of 
cholera toxin (CT) from muscarine (MU) in CHO cells. While it would be ideal to have a complete 
matrix of all toxins in all cell lines, we have chosen specific cell lines for this study with individual 
toxins in order to maximize potential metabolic changes based on the known activities of the toxins on 
these specific cell lines.  
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2. Results and Discussion 
 
2.1 Ricin Toxin (RT). 
 
Ricin toxin consists of two peptide chains, A267 and B262, linked by a disulfide bond. The toxin B 
chain reversibly binds to galactose residues of cell surface glycolipids and glycoproteins and mediates 
uptake of the toxin by endocytosis. The toxin A chain is an N-glycosidase that removes a specific 
adenine from 28 S ribosomal RNA [18], preventing the binding of an elongation factor, and leaving 
the ribosome incapable of protein synthesis [19]. 
 
Figure 1. Representative neuroblastoma response in the MMP to 100 nM Ricin. Glucose 
and oxygen extracellular concentrations are inversely proportional to cellular uptake rates. 
 
 
Neuroblastoma cells were allowed to equilibrate in the stop-flow RPMI running buffer of the MMP 
before exposure to 100 nM RT for 22 min. The cellular responses in the MMP show an increase in 
glucose uptake (GU) and oxygen uptake (OU) and a decrease in lactate production (LP) and ECAR 
during the time of exposure to RT (Figure 1). One explanation for this behavior may be that GU is 
shunted to other pathways than the production of lactate. The decrease in ECAR is likely linked to the Sensors 2009, 9                                       
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decrease in LP, since this tends to dominate the ECAR. The cell response was rapid with all 
parameters showing a significant change within the first two minutes after exposure to ricin. The 
response is also dependent on the acute presence of ricin since oxygen, lactate, and acidification 
parameters show partial recovery toward baseline levels after removal of ricin from the running buffer 
while glucose consumption significantly decreases even from the initial baseline (Figure 1). Clearly, 
the lingering effects of ricin exposure may result in significant metabolic changes from the baseline, 
and can be explored further as part of the toxin profile in the future. 
 
2.2. Botulinum Neurotoxin A (BoNT/A).  
 
The toxicity of BoNT/A is associated with disruption of synaptic vesicle function and prevention of 
neurotransmitter release [20]. Neuroblastoma cells were exposed to doses of BoNT/A (1, 10, 50, 100, 
and 500 nM), which was increased sequentially in the MMP cell media. We constructed cellular dose 
response curves (Figure 2) by averaging the MMP cell response data points (see supplemental 
material) related to each BoNT/A addition. Compared to the cells' basal metabolic response, the 
metabolic rates for all four parameters show a step-wise decrease as a function of increasing BoNT/A 
dosage. 
 
Figure 2. Representative BoNT/A kinetic metabolic profiles and partial dose response 
curves in [substrate] vs. log [BoNT/A] with sequential increasing concentration of 
BoNT/A.  
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The effect of BoNT/A on undifferentiated neuroblastoma SH-SY5Y cells has been reported to 
inhibit the production of [
3H]-noradrenaline ([
3H]-NA) and cleave synaptosomal-associated proteins of 
25 kDa (SNAP-25), but not cleave vesicle-associated membrane proteins [21-23]. Dose-response 
curves reported for the inhibition of [
3H]-NA production and cleavage of SNAP-25 using a BoNT/A Sensors 2009, 9                                       
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concentration from 0.3 to 1000 nM [21] correlates well with the marked decrease in GU, OU, LP and 
ECAR responses at concentrations of 100 nM and higher shown here. When cell exposure to BoNT/A 
was discontinued, the metabolic flux rates of all four analytes rapidly returned to near basal metabolic 
levels. 
 
2.3. Alamethicin.  
 
Alamethicin is a 20 amino acid antibiotic peptide that self-assembles to form 4–8 mer ion channels 
[24] in lipid bilayers that can mimic nerve action potential across membranes. In addition, 
concentrations of alamethicin at 7 M are reported to increase the permeability of the membrane of a 
lipid vesicle by fifteen-fold. In our study, rat airway (RAW) macrophage cells were perifused with 
low-buffered RPMI in the MMP until a steady ECAR baseline was observed. Cells were then exposed 
to RPMI buffer containing 15 M alamethicin for 20 minutes, followed by RPMI with no alamethicin. 
The cellular response to alamethicin on the short time scale is shown in Figure 3, and indicates an 
immediate decrease in the OU, LP, and ECAR. Only the GU measurement increased (seen as a 
decrease in glucose extracellular concentrations).  
 
Figure 3. Representative effect of 15 mM alamethicin on RAW macrophage cells. 
 
 
On removal of alamethicin from the perfusion medium, the cells' response showed no recovery of 
OU, LP, or ECAR to previous levels, but remained essentially the same as when alamethicin was 
present, indicating cell necrosis (which was confirmed by staining). In contrast, the extracellular Sensors 2009, 9                                       
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glucose consumption significantly decreased after removal of alamethicin from the running buffer to 
below that of the baseline rate. 
A similar range of alamethicin as in this study, 25-80 g/mL (~12 – 40 M, using an alamethicin 
m.w. = 1964.3 g/mol), led to the reduction of the membrane barrier when applied to plasma 
membranes of brain microsomes and erythrocyte and platelet membranes [25]. The upset of barrier 
function may explain the decrease in activity during perifusion with alamethicin and lack of recovery 
thereafter. It is unclear at this time why the glucose uptake alone would increase during exposure. 
 
2.4 Anthrax Protective Antigen (PA). 
 
Bacillus anthracis secretes a toxin with three components: protective antigen (PA), lethal factor 
(LF), and edema factor (EF). Delivery of LF and EF toxins to the cytosol is mediated by anthrax PA, 
which has been shown to form a heptameric prepore [10].  
 
Figure 4. Representative RAW macrophage response to 1 and 2 M anthrax PA. 
 
PA binds to a cell-surface receptor where it is cleaved into PA20, which dissociates into the 
medium, and PA63, which forms a heptamer, [PA63]7, that complexes with LF and/or EF. The complex 
is then moved through the membrane into an acidic endosomal compartment that induces a Sensors 2009, 9                                       
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conformational change in [PA63]7, allowing insertion into the membrane to form a pore. The EF and 
LF are then delivered into the cytosol [26]. 
To date there has been no report of short-term cellular effects for PA alone. We first allowed RAW 
macrophage cells to equilibrate in RPMI media without the toxin, until a steady ECAR baseline was 
observed, which was defined to be a noise of ±20 V/s, as macrophages typically did have larger 
variances in acidification rates than other cell lines. The cells were then sequentially exposed for 10 
minutes each to 1 and 2 M PA, which are very high exposure concentrations. Changes in the 
uptake/production of the four-analytes upon addition of PA are shown in Figure 4. The concentration 
of extracellular glucose and oxygen can be seen to decrease during toxin addition, indicating an 
increase in GU and OU rates. LP shows an increase in the presence of PA while the ECAR decreases, 
signaling that the lactate signal can be functionally uncoupled from the total acid production signal. 
This uncoupling of the signal may reflect the macrophages preparing to respond to foreign biological 
molecules, here the PA. In this hypothesis, the LP increases as a result of increased energy usage, 
while the apparent ECAR decreases as a result of intracellular proton storage rather than extracellular 
release. This does not mean that the acidification rate of the cells decreases, only that acid is 
sequestered intracellularly by lysosomal storage, rather than released into the extracellular 
environment. In the future, dynamic metabolic pathway analysis may help with the confirmation of the 
identification of the exact mechanism of this uncoupling. Removal of PA from the perfusion media 
results in a rapid return of macrophage metabolic indicators to pre-exposure levels. 
 
2.5. Cholera toxin and Muscarine.  
 
Cholera toxin (CT), produced by Vibrio cholerae, is an 84 kD AB5 hexamer consisting of five 
identical B subunits and a single A subunit[27]. The B subunits bind to ganglioside receptor GM1 and 
the A subunit then enters the cell. The A subunit catalyzes ADP-ribosylation of the trimeric protein 
Gs. The modified Gs loses its GTPase activity, but remains constitutively active in its GTP-bound 
state[28], causing a continuous stimulation of adenylate cyclase. Adenylate cyclase converts adenosine 
monophosphate (AMP) to cyclic AMP (cAMP), which begins to accumulate in the cell[29, 30]. cAMP 
is necessary for the cAMP-dependent protein kinase (cAPK) activity, which targets proteins involved 
in glycogen metabolism. The elevated level of cAMP activates Na
+ pumps in the lumen of the cell, 
forcing out Na
+ ions. Cl
- ions and H2O then exit the cell to balance the Na
+ release, leading to massive 
fluid loss, the characteristic pathology of CT. 
CHO cells were exposed to 1 ￿M CT in RPMI for 12 minutes. On this timescale, the cholera 
toxin B subunit has been observed in pig enterocytes to induce the formation of numerous clathrin-
coated pits and vesicles between adjacent microvilli and to appear in an endosomal subapical 
compartment [31]. Figure 5 shows the change in analyte concentrations during acute exposure of CHO 
cells to CT. OU increases while GU, LP and ECAR all show a decrease on cell exposure to CT. The 
observed decrease in GU is consistent with earlier observations in neuronal cells [32]. The decrease in 
LP and ECAR may be consistent with CT stimulating the production of adenylate cyclase, which 
would lead to metabolism of small glycogen stores, characteristic of CHO cells [33]. The OU rate 
increase may be a result of the increased cellular metabolic demand [34], such as an increase in 
production of cAMP, protein synthesis-dependent prostaglandin formation [35,36], and morphological Sensors 2009, 9                                       
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elongation[36,37]. A correlation between increased OU and intestinal volume secretion was seen 
during exposure to CT in autoperfused segments of cat ileum [34]. In this study, the OU rate increased 
due to the increased metabolic work incurred from the CT induced secretory states of the small 
intestine, which was larger than the metabolic work of the absorptive state. 
 
Figure 5. Representative CHO cell response to 1 M cholera toxin followed by stimulation 
with 10 M muscarine.  
 
 
After removal of CT from the perfusion media, the cells essentially returned to pre-exposure levels, 
after which we stimulated them with 10 M muscarine to check for possible antagonist behavior or 
activation of similar pathways of CT. Exploring toxin antagonist behavior is readily possible after 
exposure by simulating with a native agonist like muscarine. In response to muscarine, OU and ECAR 
significantly increased before rapidly returning to previous levels, while the GU and LP show a 
somewhat slower response (increase) followed by a return to baseline rates. Here the LP does not 
specifically track the immediate ECAR increase, but increases for several cycles after the ECAR spike 
before returning to baseline.  This may be due to the production of arachidonic acid [38], which would 
tend to increase ECAR, yet not be detected at the lactate electrode.  This ECAR spike was smaller 
after CT exposure than without previous exposure. Thus, in addition to direct metabolic effects by the 
toxin, toxins acting as antagonists can also be evaluated by multianalyte microphysiometry. 
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2.6 Discussion and Interpretation  
 
This study was designed to determine the ability of dynamic, multianalyte microphysiometry to 
discriminate between toxins. Comparison of the metabolic flux responses of neuroblastoma cells 
exposed to RT and BoNT/A revealed a differing response in the glucose and oxygen consumption 
rates, with RT causing an increase in both and BoNT/A causing a decrease in all four metabolic 
analytes. Anthrax PA was distinguishable from alamethicin by observing changes in the macrophage 
oxygen and lactate metabolic fluxes despite the fact that both are considered “pore-forming” proteins. 
In both cases, the GU increased and ECAR decreased, but the PA caused a differential increase in OU 
and LP. The response of CHO cells to CT was also different than stimulation by MU, and that which 
we reported previously [17] for DNP and NaF. NaF exposure decreased the metabolic rates of all four 
analytes, while CT increased only OU. DNP (at lower concentrations) increased both LP and ECAR, 
while MU increased the flux rates of three of the analytes - OU, LP, and ECAR. This case shows 
discrimination between four agents in the metabolic responses of CHO cells. 
While the absolute magnitudes of the metabolic effects observed can vary as much as 20% for each 
experimental replicate, the overall trends are reproducible. If we plot the different responses of the 
cells to each of the metabolic agents as a variable Karnaugh map (logic table), where the analytes are 
the four axes, we can see as a simple map (Figure 6) of metabolic response from all of the different 
patterns (Figure 7).  
 
Figure 6. Binary four-by-four Karnaugh map of toxin responses. A '0' indicates a decrease 
and a '1' indicates an increase in the rate of consumption/production of analyte in response 
to the indicated analyte. BT = botulinum neurotoxin A, CT = cholera toxin, DNP = 2,4-
dinitrophenol, MU = muscarine, APA = anthrax protective antigen, Ala = alamethicin, RT 
= ricin toxin, NaF = sodium fluoride. DNP, NaF from ref. [17]. 
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Figure 7. Combined representative metabolic profiles of all toxins for comparison in Figure 6. 
 
 
 
 
Here, a decrease in metabolic activity associated with a particular agent is assigned a ‘0’, whereas 
an increase is assigned a ‘1’. The map reveals a simple differentiation between each of the various 
agents based on the summary of the cellular response across each of the four metabolic parameters. 
Although we have employed different cell lines to discriminate between the agents tested here, our 
working hypothesis is that the selection of different cell lines will give different response profiles for 
all the list agents. The ideal is to have one map for each cell line at a given analyte concentration. We 
are presently examining the exposure of select cell lines to each agent in order to detect those 
responses that are unique to a particular agent, since not all cell lines are affected by agents in the same 
way[39]. Additional parameters, such as cell type, dose-response and temporal dynamics of the onset 
and recovery response could add further dimensions of discrimination. 
One would expect that GU, OU, LP and ECAR reflect some degree of covariance, where changes in 
one parameter will necessarily alter the others due to an upset in the basal metabolism of the cells. One Sensors 2009, 9                                       
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would predict a priori that GU - OU and LP - ECAR parameter pairings would reflect strong covariant 
relationships. Our results show that bioagents effect an unexpected dissociation between the metabolic 
parameters. Both Cholera toxin and alamethicin effect dissociation between GU and OU while anthrax 
PA functionally uncouples the expected correlation between LP and the overall ECAR. The Karnaugh 
map also does not take into account the temporal dynamics of agent exposure, which can add a further 
dimension to agent discrimination. The potential for temporal dynamics to aid agent discrimination is 
illustrated in the case with MU exposure, where the changes in GU and LP occur several measurement 
cycles behind the OU and ECAR. Dose-response relationships will also be important predictors since 
different concentrations can elicit different metabolic responses, such as with DNP, where low 
concentrations increase the LP and ECAR parameters, while high concentrations decrease all four 
metabolic rate measurements. Addition of these factors to a metabolic profile of agent effect on cells 
may create more complex 'biosignatures' and greatly extend the range of agent discrimination within 
and between cell lines [40]. 
With the exception of alamethicin and cholera toxin, little is known about the cellular mechanisms 
through which acute exposure to ricin, botulinum neurotoxin A, and protective antigen affect general 
cell metabolism. Interpretation of these data would be significantly enhanced by the use of an inverse 
dynamic metabolic model, wherein the interconnections and temporal relations between known 
metabolic and signaling pathways could be employed to identify agent specific mechanisms of cell 
toxicity. However, quantitative, dynamic analysis of the data shown in Figures 1-3 and 5 would 
require an analytical model that would allow for the deconvolution of lateral diffusion within the 
measurement chamber and sensor response kinetics. These results will be further enhanced by 
additional statistical analysis of the metabolic responses. Given the limitations in the access to larger 
quantities of select list agents, it is not possible to include a complete statistical analysis of all of the 
metabolic data at this time, but we believe that the general trends of metabolic responses are enough to 
show cell-based agent detection and at least partial discrimination of these select list agents. 
 
3. Experimental Section  
 
Materials and Reagents  
 
Glucose oxidase (GOx, Aspergillus niger), lactate oxidase (LOx, Pediococcus), bovine serum 
albumin (BSA, Fraction V, 96%), glutaraldehyde (glutaric dialdehyde, 25 wt.% solution in water), and 
alamethicin (from Trichoderma viride) were from Sigma. RPMI 1640 buffer and all Cytosensor 
consumable materials were from Molecular Devices Corporation (Sunnyvale, Ca). Phosphate buffered 
saline (PBS, 1 mM in phosphate, pH 7) was prepared fresh from stock solutions. Nafion 
(Perfluorosulfonic acid-PTFE copolymer, 5% w/w solution) was from Alfa Aesar, sodium fluoride 
(>98%) was from Fluka, and the platinum wire (24 and 36 gauge, 99.9%) was from VWR. Botulinum 
toxin A (from Clostridium botulinum), Cholera toxin (whole, A&B subunits from Vibrio cholerae), 
and Ricin communis agglutin (RCA60, includes both A&B chains) were from Sigma Chemical. 
Anthrax PA was provided by Jim Crowe, Vanderbilt Pediatric Immunology and Southeast Regional 
Center of Excellence in Biodefense (SERCEB). Neuroblastoma cells (ATCC HTB-11, Human SK-N-
SH) were cultured in Eagle's Minimal Essential Medium with Earle's BSS and supplemented with 2 Sensors 2009, 9                                       
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mM L-glutamine, 1.0 mM sodium pyruvate, 0.1 mM nonessential amino acids, 1.5 g/L sodium 
bicarbonate and 10% fetal bovine serum. The cells were cultured to confluence in 125 mL flasks under 
5% CO2 and passaged twice before being seeded in the Cytosensor capsules. Cells were prepared for 
Cytosensor use by dissociating the culture with 0.25% Trypsin/0.03% EDTA, diluted to 15 mL with 
growth medium and centrifuged at 5000 rpm for 5 min. The cells were then re-suspended in growth 
medium to achieve ~5x10
5 cells/mL and added to the Cytosensor inserts to a final concentration of 
~2.5x10
5 cells per insert. The inserts were incubated overnight at 30
oC in a 5% CO2 atmosphere. RAW 
264.7 macrophage cells (~5x10
5 per insert, ATCC TIB-71) were cultured in RPMI 1640 adjusted with 
2 g/L sodium bicarbonate (Sigma), with 10% fetal bovine serum and 100 units/mL penicillin and 
streptavidin.  CHO cell lines (ATCC # CRL-1981 M3WT4; CHO, Chinese hamster ovary) were 
cultured in Ham's F12 medium with 0.05 to 0.1 mg/ml G418, 90%; fetal bovine serum, 10%. All cell 
lines were seeded using the same procedure above. 
 
Sensor Head Construction.  
 
Cytosensor Microphysiometer plunger heads were modified with platinum sensors as described 
previously[17,41]. Briefly, platinum wires (24 gauge) were sealed into holes drilled through the body 
of a typical Cytosensor
 Microphysiometer plunger head. The oxygen electrode was a smaller 
platinum wire (36 gauge) attached by silver epoxy (Epoxy Technology, Inc., Billerica MA) to the 
larger Pt wire. Polyurethane (Crystal Clear 200 from Smooth-On, Inc.) was used to seal the back of the 
electrode to provide electrical insulation and mechanical protection, with a hole left for the Cytosensor 
plunger. The electrodes were then polished flush with the surface of the plunger face. The 
microphysiometer chamber had a total volume of ~3.5 microliters, of which approximately 1 microliter 
was filled by the biological cells’ volume. 
 
Enzyme Solutions  
 
The oxidase enzyme solutions were prepared similarly to that described previously [17, 41]. For the 
oxidase film solutions, 50 mg of BSA was dissolved in 700 L of 50 mM phosphate buffer. For the 
GOx solution, 5 mg of GOx was thoroughly dissolved in 600 L of the BSA solution then quickly 
mixed with 6 L of 25% glutaraldehyde solution. For the LOx film, ~ 0.25 mg of LOx was dissolved 
in 70 L of the BSA solution then quickly mixed with 0.7 L of 25% glutaraldehyde solution. The 
solutions were prepared fresh when needed. 
 
Electrode Film Preparations  
 
The modified sensor head electrodes were first rinsed with ethanol and distilled water. As described 
elsewhere[17,41], the enzyme electrode films were then prepared by allowing a droplet of the enzyme 
solution to dry on the platinum electrode surface. The LOx/BSA film was used as prepared in this 
manner. The GOx/BSA film was further modified by coating with a droplet of 5% w/w Nafion 
solution. A droplet of the 5% Nafion solution was also applied to the oxygen electrode (127 m bare 
platinum wire) to reduce biofouling as shown in the literature [16,42,43]. The sensor heads with the Sensors 2009, 9                                       
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modified electrodes were stored dry at room temperature when not in use, and were useful for 
measurements for more than 2 months. 
 
Electrochemical Measurements  
 
The acidification rates were obtained with the sensor and electronics internal to the Cytosensor
 
Microphysiometer (Molecular Devices, Inc.), while the glucose, lactate and oxygen measurements 
were obtained using a CHI 1030 Multipotentiostat (CH Instruments, Austin, TX). The glucose and 
lactate electrodes were set at +0.6 V in the ‘amperometric i-t curve’ to oxidize hydrogen peroxide. The 
oxygen electrode was set at -0.45 V to reduce dissolved oxygen or traces of other partially reduced 
oxygen species like hydrogen peroxide.  All potentials were set versus the Cytosensor Ag/AgCl 
reference electrode in the effluent stream. 
 
Apparatus Operation  
 
The acidification rates were obtained in the usual manner using the microphysiometer plunger and 
pump-on/pump-off program (80 s pump-on, 40 s pump-off). The glucose, lactate, and oxygen 
electrodes added to the plunger were attached to the CHI 1030 working electrodes, while the 
remaining platinum electrode on the sensor head was used as the CHI 1030 counter electrode. Both 
instruments shared the same reference electrode and experienced the same pump-on/pump-off program 
as applied by the microphysiometer. Minimal noise was encountered with the electrodes attached in 
this manner. 
 
Data Interpretation  
 
The ECAR data was recorded in the usual manner from the Cytosensor, which was plotted as -V/s 
vs. time (s). The changes in GU, OU, and LP rates were estimated by calculating the area under the 
curve during pump-off. The areas were calculated from zero current for glucose and oxygen, while the 
lactate area was calculated from the current baseline during flow. The normal decay current for the 
entire curve was corrected for by dividing the pump-off curve area by the pump-on baseline just before 
that respective curve. The resulting data points were then plotted as signal vs. time. The glucose and 
lactate signals were converted to concentrations by adding internal calibrations of glucose (1 mM 
aliquots) and lactate (0.1 or 0.2 mM aliquots) at the end of the experiment. The increase in signal 
during pump-off, as measured from the original flow baseline, was then used as the analyte calibration. 
The flow baseline was assumed to be the original solution concentration for each analyte with ~10 mM 
for glucose, 0 mM for lactate, and ~0.24 mM for oxygen. In this manner, the glucose and oxygen 
signals are inversely proportional to the cellular consumption rate. Therefore, a decrease in signal for 
the glucose and oxygen electrodes would be interpreted as a decrease in glucose and oxygen solution 
concentration, and thus an increase in the rate of cellular glucose and oxygen consumption. For the 
lactate electrode, a decrease in signal relates directly to a decrease in cellular lactate production. 
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4. Conclusions  
 
Our results have shown that the multianalyte microphysiometer can be a powerful tool in the 
characterization of cellular metabolic activity after acute exposure to biological toxins. In addition, we 
have shown that toxins can produce unique profiles of cellular metabolic responses that permit 
discrimination between agents based on the cellular response to exposures measured in minutes versus 
hours. Dynamic metabolic flux analysis, coupled to the MMP data, should prove useful in building 
metabolic biosignatures for each selected agent. This may require the incorporation of more specific 
probes for analytes such as potassium, calcium, NO, glutamate, amino acids, etc. MMP technology can 
be readily applied to the construction and monitoring of heterogeneous cell-based analytical platforms 
and afford greater confidence in assessing/predicting toxicity of exogenous drugs across different cell 
populations. Further development of metabolic profiling using the MMP technology may eventually 
lead to a new cell-based sensor system for toxin identification based on the proof of concept presented 
here. 
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